Document:

Voting Agreement

 Exhibit 4.1 
  
 COMPANY VOTING AGREEMENT 
  
 THIS VOTING AGREEMENT (this “Agreement”) is made and entered into as of December 13, 2004, by and among 3Com Corporation, a Delaware
corporation (“Parent”), TippingPoint Technologies, Inc., a Delaware corporation (the “Company”), and the undersigned stockholder (“Stockholder”) of the Company. 
  
 RECITALS 
  
 A. Concurrently with the execution of this Agreement, Parent and the Company have entered into an Agreement and Plan of
Merger (the “Merger Agreement”), which provides for the merger (the “Merger”) of a wholly owned subsidiary of Parent with and into the Company. 
  
 B. Pursuant to the Merger, all of the issued and outstanding shares of capital stock of the Company will be canceled and
converted into the right to receive the consideration set forth in the Merger Agreement, all upon the terms and subject to the conditions set forth in the Merger Agreement. 
  
 C. As of the date hereof, Stockholder is the beneficial owner (as defined in Rule 13d-3 under the Securities Exchange Act of
1934, as amended (the “Exchange Act”)) of the number of shares of outstanding capital stock of the Company (the “Shares”) and other securities convertible into, or exercisable or exchangeable for, shares of capital
stock of the Company, all as set forth on the signature page of this Agreement. 
  
 D. As a material inducement to Parent to enter into and to consummate the transactions contemplated by the Merger Agreement, Parent has required that Stockholder agree, and Stockholder is willing to agree, to restrict
the transfer or disposition of any of the Shares, or any other shares of capital stock of the Company acquired by Stockholder hereafter and prior to the Expiration Time (as defined in Section 1(a) hereof), and to vote the Shares and any other
such shares of capital stock of the Company as set forth in this Agreement. 
  
 NOW, THEREFORE, the parties hereto hereby agree as follows: 
  
 1. Agreement to Retain Shares. 
  
 (a) Transfer. Stockholder agrees that, at all times during the period beginning on the date hereof and ending at the Expiration Time, Stockholder shall not Transfer (as defined below) any of the Shares or any New Shares (as defined
in Section 1(b) hereof), or make any agreement regarding any Transfer, in each case without the prior written consent of Parent. Stockholder agrees that any Transfer in violation of this Agreement shall be void and of no force or effect.

  
 As used herein, the term “Expiration Time”
shall mean the earlier to occur of (i) such date and time as the Merger shall become effective in accordance with the terms and provisions 

 of the Merger Agreement, or (ii) the termination of the Merger Agreement in accordance with the terms thereof. As used
herein, the term “Transfer” shall mean, with respect to any security, the direct or indirect assignment, sale, transfer, tender, pledge, hypothecation, or the gift, placement in trust, or the Constructive Sale (as defined below) or
other disposition of such security (excluding transfers by testamentary or intestate succession or otherwise by operation of law) or any right, title or interest therein (including, but not limited to, any right or power to vote to which the holder
thereof may be entitled, whether such right or power is granted by proxy or otherwise), or the record or beneficial ownership thereof, the offer to make such a sale, transfer, Constructive Sale or other disposition, and each agreement, arrangement
or understanding, whether or not in writing, to effect any of the foregoing, excluding any Transfer (A) pursuant to a court order, (B) pursuant to the Merger, or (C) to any affiliate or family member of Stockholder if such transferee, prior to the
Transfer, executes a binding agreement with Parent and the Company substantially in the form of this Agreement. As used herein, the term “Constructive Sale” shall mean, with respect to any security, a short sale with respect to such
security, entering into or acquiring an offsetting derivative contract with respect to such security, entering into or acquiring a futures or forward contract to deliver such security or entering into any other hedging or other derivative
transaction that has the effect of materially changing the economic benefits and risks of ownership. 
  
 (b) New Shares. Stockholder agrees that any shares of capital stock of the Company that Stockholder purchases or with respect to which Stockholder
otherwise acquires beneficial ownership after the date of this Agreement and prior to the Expiration Time, including, without limitation, shares issued or issuable upon the conversion, exercise or exchange, as the case may be, of all securities held
by Stockholder which are convertible into, or exercisable or exchangeable for, shares of capital stock of the Company (“New Shares”), shall be subject to the terms and conditions of this Agreement to the same extent as if they
constituted Shares as of the date hereof. 
  
 2. Agreement to
Vote Shares. Until the Expiration Time, at every meeting of stockholders of the Company called with respect to any of the following, and at every adjournment or postponement thereof, and on every action or approval by written consent of
stockholders of the Company with respect to any of the following, Stockholder shall vote, to the extent not voted by the person(s) appointed under the Proxy (as defined in Section 3), the outstanding Shares and any outstanding New Shares (to
the extent any such New Shares may be voted): 
  
 (i) in favor of
approval and adoption of the Merger Agreement and in favor of each of the other actions contemplated by the Merger Agreement and the Proxy and any action required in furtherance thereof; 
  
 (ii) against approval of any proposal made in opposition to, or in competition with, consummation of the Merger and the
transactions contemplated by the Merger Agreement; 
  
 (iii)
against any of the following actions (other than those actions contemplated by the Merger Agreement): (A) any merger, consolidation, business combination, sale of assets, 
  

 2 

 reorganization or recapitalization of the Company or any subsidiary of the Company with any party, (B) any sale, lease,
license or transfer of any significant part of the assets of the Company or any subsidiary of the Company, (C) any reorganization, recapitalization, dissolution, liquidation or winding up of the Company or any subsidiary of the Company, (D) any
material change in the capitalization of the Company or any subsidiary of the Company, or the corporate structure of the Company or any subsidiary of the Company, or (E) any other action that is intended, or could reasonably be expected to, impede,
interfere with, delay, postpone, discourage or adversely affect the Merger or any of the other transactions contemplated by the Merger Agreement; and 
  
 (iv) in favor of waiving any notice that may have been or may be required relating to any reorganization of the Company or any subsidiary of the Company,
any reclassification or recapitalization of the capital stock of the Company or any subsidiary of the Company, any sale of assets, change of control or acquisition of the Company or any subsidiary of the Company by any other person, or any
consolidation or merger of the Company or any subsidiary of the Company with or into any other person.  
  
 Prior to the Expiration Time, Stockholder shall not enter into any agreement or understanding with any person to vote or give instructions in any manner
inconsistent with this Section 2. 
  
 3. Irrevocable
Proxy. Concurrently with the execution of this Agreement, Stockholder agrees to deliver to Parent an irrevocable proxy in the form attached hereto as Appendix A (the “Proxy”), which shall be irrevocable to the fullest
extent permitted by applicable law, covering the total number of Shares and New Shares. 
  
 4. Representations, Warranties and Covenants of Stockholder. Stockholder represents, warrants and covenants to Parent as follows: 
  
 (i) Stockholder is the beneficial owner of the Shares, with full power to vote or direct the voting of the Shares for and on
behalf of any and all beneficial owners of the Shares. 
  
 (ii) As
of the date hereof, the Shares are, and at all times up until the Expiration Time the Shares will be, free and clear of any rights of first refusal, co-sale rights, security interests, liens, pledges, claims, options, charges or other encumbrances
of any kind or nature, in each case that would impair Stockholder’s ability to fulfill its obligations under Section 2, other than the number of Shares listed on the signature page to this Agreement that are pledged to the individual
listed on the signature page to this Agreement pursuant to a pledge agreement and note (the “Pledged Shares”), which Pledged Shares are, and at all times up until the Expiration Time will be, subject in all respects to a voting
agreement and proxy that (A) is identical to this Agreement and the Proxy (except as to the identity of Stockholder and the number of Shares beneficially owned by such Stockholder) and (B) obligates the holder of such Pledged Shares to vote all such
Pledged Shares in the manner set forth in Section 2 hereof and the Proxy. The execution and delivery of this Agreement by Stockholder do not, and Stockholder’s performance of its obligations under this Agreement will not conflict with or
violate any order, decree, judgment or agreement applicable to Stockholder or by which Stockholder or any of Stockholder’s properties or Shares is bound. 
  

 3 

 (iii) Stockholder does not beneficially own any shares of capital stock of the Company, or any securities
convertible into, or exchangeable or exercisable for, shares of capital stock of the Company, other than as set forth on the signature page hereto. 
  
 (iv) Stockholder has full power and authority to make, enter into and carry out the terms of this Agreement, the Proxy and any other related agreements to
which Stockholder is a party. 
  
 (v) Stockholder shall not take
any action that the Company is prohibited from authorizing or permitting any Representative (as defined in the Merger Agreement) from taking under Section 5.4(a) of the Merger Agreement, whether or not Stockholder is or remains a Representative.

  
 (vi) Stockholder agrees that it will not bring, commence,
institute, maintain, prosecute, participate in or voluntarily aid any action, claim, suit or cause of action, in law or in equity, in any court or before any governmental entity, which (a) challenges the validity of or seeks to enjoin the operation
of any provision of this Agreement or (b) alleges that the execution and delivery of this Agreement by Stockholder, either alone or together with the other Company voting agreements and proxies to be delivered in connection with the execution of the
Merger Agreement, or the approval of the Merger Agreement by the board of directors of the Company, breaches any fiduciary duty of the board of directors of the Company or any member thereof; provided, that Stockholder may defend against,
contest or settle any such action, claim, suit or cause of action brought against Stockholder that relates solely to Stockholder’s capacity as a director or officer of the Company. 
  
 (vii) Stockholder hereby agrees and covenants that, as soon as practicable after the date hereof, Stockholder shall take any
and all actions reasonably necessary to suspend (until the Expiration Time) or terminate any and all plans adopted pursuant to Rule 10b5-1 promulgated under the Exchange Act to which such Stockholder is a party that relate to the Shares (each, a
“10b5-1 Plan”). 
  
 5. Additional
Documents. Stockholder hereby covenants and agrees to execute and deliver any additional documents reasonably necessary or desirable to carry out the purpose and intent of this Agreement. 
  
 6. Consents and Waivers. Stockholder hereby gives any consents or
waivers that are reasonably required for the consummation of the Merger under the terms of any agreement or instrument to which Stockholder is a party or subject or in respect of any rights Stockholder may have. Stockholder further consents to the
Company placing a stop transfer order on the Shares and any New Shares with its transfer agent(s) in accordance with Section 8. 
  

 4 

 7. Termination. This Agreement and the Proxy delivered in connection herewith shall terminate
automatically and shall have no further force or effect as of the Expiration Time. 
  
 8. Company Covenants. The Company agrees to make a notation on its records and give instructions to its transfer agent(s) to not permit, prior to the Expiration Time, the transfer of any Shares or New Shares,
except as permitted pursuant to Section 1(a). 
  
 9.
Miscellaneous. 
  
 (a) Directors and Officers.
Notwithstanding any provision of this Agreement to the contrary, Stockholder has entered into this Agreement in his or her capacity as a Stockholder of the Company, and nothing in this Agreement shall limit or restrict Stockholder from acting, if
applicable, in the Stockholder’s capacity as a director or officer of the Company (it being understood that this Agreement shall apply to Stockholder solely in Stockholder’s capacity as a stockholder of the Company) or voting in
Stockholder’s sole discretion on any matter other than those matters referred to in Section 2. Parent covenants that it will not bring, commence, institute, maintain, prosecute, participate in or voluntarily aid any action, claim, suit
or cause of action, in law or in equity, in any court or before any governmental entity, which (i) alleges that any action taken (or not taken) by Stockholder solely in Stockholder’s capacity as a director or officer of the Company breaches or
violates or would breach or violate any provision of this Agreement or the Proxy or (ii) challenges the right of Stockholder to vote or challenges the validity of or seeks to enjoin any vote by Stockholder on any matter other than those matters set
forth in Section 2. 
  
 (b) Waiver. No waiver by any
party hereto of any condition or any breach of any term or provision set forth in this Agreement shall be effective unless in writing and signed by the other party hereto. The waiver of any breach of any term or provision of this Agreement shall not
operate as or be construed to be a waiver of any other previous or subsequent breach of any term or provision of this Agreement. No delay or omission by Parent in exercising any right under this Agreement shall operate as a waiver of that right or
any other right under this Agreement. 
  
 (c) Notices. All
notices and other communications hereunder shall be in writing and shall be deemed duly given (i) on the date of delivery if delivered personally, (ii) on the date of confirmation of receipt (or the first business day following such receipt if the
date is not a business day) if sent via facsimile (receipt confirmed), or (iii) on the date of confirmation of receipt (or the first business day following such receipt if the date is not a business day) if delivered by a nationally recognized
courier service. All notices hereunder shall be delivered to the parties at the following addresses or facsimile numbers (or pursuant to such other instructions as may be designated in writing by the party to receive such notice): 
  

	 	(i)	if to Parent, to: 

  
 350 Campus Drive 
 Marlborough, Massachusetts 01752 
 Attention: General Counsel 
 Telephone: (508) 323-5000 
 Facsimile: (508) 323-1044 
  

 5 

 with a copy to: 
  
 Wilson Sonsini Goodrich & Rosati 
 Professional Corporation 
 650 Page Mill Road 
 Palo Alto, California 94304 
 Attention: Katharine A. Martin 
 Facsimile: (650) 493-6811 
  
 and to: 
  
 Wilson Sonsini Goodrich & Rosati 
 Professional Corporation 
 12 East 49th Street 
 30th Floor 
 New York City, New York 10017-8203 
 Attention: Robert D. Sanchez 
 Facsimile: (212) 999-5899 
  

	 	(ii)	if to Company, to: 

  
 7501B N. Capital of Texas Highway 
 Austin, Texas 78731 
 Attention: General Counsel 
 Telephone: (512) 681-8000 
 Facsimile: (512) 681-8499 
  
 with a copy to: 
  
 Vinson & Elkins L.L.P. 
 The Terrace 7 
 2801 Via Fortuna 
 Suite 100 
 Austin, Texas 78746-7568 
 Attention: Kyle Fox, Esq. 
 Facsimile: (512) 542-8612 
  

 6 

	 	(iii)	if to Stockholder: To the address for notice set forth on the signature page hereof. 

  
 (d) Headings. All captions and section headings used in this Agreement are for convenience only and do not form a
part of this Agreement. 
  
 (e) Counterparts. This
Agreement may be executed in one or more counterparts, all of which shall be considered one and the same agreement and shall become effective when one or more counterparts have been signed by each of the parties and delivered to the other party, it
being understood that all parties need not sign the same counterpart. 
  
 (f) Entire Agreement; Amendment. This Agreement constitutes the entire agreement among the parties with respect to the subject matter hereof and supersedes all prior agreements and understandings, both written and oral, among the
parties with respect to the subject matter hereof. This Agreement may not be changed or modified, except by an agreement in writing specifically referencing this Agreement and executed by each of the parties hereto. 
  
 (g) Severability. In the event that any provision of this Agreement,
shall be determined to be invalid, unlawful, void or unenforceable to any extent, the remainder of this Agreement shall not be impaired or otherwise affected and shall continue to be valid and enforceable to the fullest extent permitted by law.

  
 (h) Governing Law. This Agreement shall be governed by
and construed in accordance with the laws of the State of Delaware, regardless of the laws that might otherwise govern under applicable principles of conflicts of law thereof. 
  
 (i) Rules of Construction. The parties hereto agree that they have been represented by counsel during the negotiation
and execution of this Agreement and, therefore, waive the application of any law, regulation, holding or rule of construction providing that ambiguities in an agreement or other document will be construed against the party drafting such agreement or
document. 
  
 (j) Remedies. The parties acknowledge that
Parent will be irreparably harmed and that there will be no adequate remedy at law for a violation of any of the covenants or agreements of Stockholder set forth herein. Therefore, it is agreed that, in addition to any other remedies that may be
available to Parent upon any such violation, Parent shall have the right to enforce such covenants and agreements by specific performance, injunctive relief or by any other means available to Parent at law or in equity. 
  
 (k) No Assignment. Unless otherwise provided for herein, Stockholder
may not assign this Agreement. This Agreement shall inure to the benefit of Parent, Company and their respective successors and assigns. 
  
 [Remainder of Page Intentionally Left Blank] 
  

 7 

 IN WITNESS WHEREOF, the undersigned have executed this Agreement on the date first above written.

  

											
	3COM CORPORATION	  	 	 	STOCKHOLDER:
				
	 By:
	  	 /s/ Neal D. Goldman

	  	 	 	 /s/ John McHale

	 Name:
	  	 Neal D. Goldman
	  	 	 	 Signature

	 Title:
	  	Senior Vice President, Management	  	 	 	 
	 	  	Services, General Counsel and Secretary	  	 	 	                 John McHale

	 	  	 	  	 	 	                 Print Name

			
	TIPPINGPOINT TECHNOLOGIES, INC.	  	 	 	  

				
	 	  	 	  	 	 	  

	 By:
	  	 /s/ Adam Chibib

	  	 	 	 Address

	 Name:
	  	 Adam Chibib
	  	 	 	 
	 Title:
	  	 Chief Financial Officer
	  	 	 	 Shares:
                    

				
	 	  	 	  	 	 	 Company Common Stock:     1,280,387

				
	 	  	 	  	 	 	 Company Options:                                   
     

				
	 	  	 	  	 	 	 McHale – Matheson Foundation

				
	 	  	 	  	 	 	 Company Common Stock: 66,667

  
 [SIGNATURE PAGE TO
COMPANY VOTING AGREEMENT] 

 APPENDIX A 
  

IRREVOCABLE PROXY 
  
 The undersigned stockholder (“Stockholder”) of TippingPoint Technologies, Inc., a Delaware corporation (the “Company”),
hereby irrevocably (to the fullest extent permitted by law) appoints Bruce L. Claflin and Neal D. Goldman of 3Com Corporation, a Delaware corporation (“Parent”), and each of them, as the sole and exclusive attorneys-in-fact and
proxies of the undersigned, with full power of substitution and resubstitution, to vote and exercise all voting and related rights (to the full extent that the undersigned is entitled to do so) with respect to all of the shares of capital stock of
the Company that now are or hereafter may be beneficially owned by the undersigned, and any and all other shares or securities of the Company issued or issuable in respect thereof on or after the date hereof (collectively, the
“Shares”), in accordance with the terms of this Proxy until the Expiration Time (as defined in the that certain Voting Agreement, dated of even date herewith, by and among Parent, the Company and Stockholder (the “Voting
Agreement”)). The Shares beneficially owned by the undersigned stockholder of the Company as of the date of this Proxy are listed on the final page of this Proxy. Upon the undersigned’s execution of this Proxy, any and all prior
proxies given by the undersigned with respect to any Shares are hereby revoked and the undersigned hereby agrees not to grant any subsequent proxies with respect to the Shares until after the Expiration Time (as defined in the Voting Agreement).

  
 This Proxy is irrevocable (to the fullest extent permitted by
law), is coupled with an interest and is granted pursuant to the Voting Agreement, and is granted in consideration of Parent entering into that certain Agreement and Plan of Merger, dated as of December 13, 2004, by and among Parent, the Company and
certain other parties (the “Merger Agreement”). The Merger Agreement provides for the merger of a wholly owned subsidiary of Parent with and into the Company in accordance with its terms (the “Merger”), and
Stockholder is receiving a portion of the proceeds of the Merger. 
  
 The attorneys-in-fact and proxies named above are hereby authorized and empowered by the undersigned, at any time prior to the Expiration Time (as defined in the Voting Agreement), to act as the undersigned’s attorney-in-fact and proxy
to vote the Shares, and to exercise all voting, consent and similar rights of the undersigned with respect to the Shares (including, without limitation, the power to execute and deliver written consents), at every annual, special, adjourned or
postponed meeting of stockholders of the Company and in every written consent in lieu of such meeting: 
  
 (i) in favor of approval and adoption of the Merger Agreement and in favor of each of the other actions contemplated by the Merger Agreement and this
Proxy and any action required in furtherance thereof; 

 (ii) against approval of any proposal made in opposition to, or in competition with, consummation of the
Merger and the transactions contemplated by the Merger Agreement; 
  
 (iii) against any of the following actions (other than those actions contemplated by the Merger Agreement): (A) any merger, consolidation, business combination, sale of assets, reorganization or recapitalization of the Company or any
subsidiary of the Company with any party, (B) any sale, lease, license or transfer of any significant part of the assets of the Company or any subsidiary of the Company, (C) any reorganization, recapitalization, dissolution, liquidation or winding
up of the Company or any subsidiary of the Company, (D) any material change in the capitalization of the Company or any subsidiary of the Company, or the corporate structure of the Company or any subsidiary of the Company, or (E) any other action
that is intended, or could reasonably be expected to, impede, interfere with, delay, postpone, discourage or adversely affect the Merger or any of the other transactions contemplated by the Merger Agreement; and 
  
 (iv) in favor of waiving any notice that may have been or may be required
relating to any reorganization of the Company or any subsidiary of the Company, any reclassification or recapitalization of the capital stock of the Company or any subsidiary of the Company, any sale of assets, change of control or acquisition of
the Company or any subsidiary of the Company by any other person, or any consolidation or merger of the Company or any subsidiary of the Company with or into any other person. 
  
 The attorneys-in-fact and proxies named above may not exercise this Proxy on any other matter except as provided in clauses
(i), (ii), (iii) or (iv) above, and Stockholder may vote the Shares on all other matters. 
  
 Any obligation of the undersigned hereunder shall be binding upon the successors and assigns of the undersigned. 
  
 This Proxy shall terminate, and be of no further force and effect, automatically as of the Expiration Time. 
  
 [Remainder of Page Intentionally Left Blank] 

 
 ***** 
  

 2 

 This Proxy shall terminate, and be of no further force and effect, automatically upon the Expiration Time
(as defined in the Voting Agreement). 
  
 Dated: December 13, 2004 
  

					
	                 /s/ John McHale

	 Signature

	
	                 John McHale

	 Print Name

	  

	  

	 Address

	
	 Shares:

	
	 Company Common Stock:     1,280,387

	
	 Company Options:                                  
      

	
	 McHale – Matheson Foundation

	
	 Company Common Stock: 66,667

  
 [SIGNATURE
PAGE TO PROXY]ViroPharma Cash Bonus Plan

 Exhibit 10.1 
  
 ViroPharma Cash Bonus Plan 
  
 The ViroPharma Incorporated Cash Bonus Plan applies to each of our employees, including the members of our management team. Each employee receives a target bonus,
expressed as a percentage of his or her base salary for the year. The amount of a specific employee’s target bonus varies by the employee’s role in the Company and his or her applicable pay band, as identified in the table below:

  
 Exempt Positions 
  

									
	 Position

	  	Pay Band(s)

	  	Target

	 	 	Maximum

	 
	 CEO
	  	17	  	50	%	 	62.5	%
	 Management Team
	  	16B	  	50	%	 	62.5	%
	 Management Team
	  	16A	  	40	%	 	50	%
	 Director
	  	15B	  	30	%	 	37.5	%
	 Director
	  	15A	  	20	%	 	25	%
	 Manager
	  	14	  	20	%	 	25	%
	 Manager
	  	13B	  	20	%	 	25	%
	 Manager
	  	13A	  	15	%	 	18.75	%
	 Senior Professional
	  	12	  	15	%	 	18.75	%
	 Senior Professional
	  	11B	  	15	%	 	18.75	%
	 Senior Professional
	  	11A	  	12	%	 	15	%
	 Mid-level Professional
	  	10	  	12	%	 	15	%
	 Professional
	  	9	  	12	%	 	15	%
	 Entry Level
	  	7-8	  	10	%	 	12.5	%
				
	 Non-Exempt Positions
	  	 	  	 	 	 	 	 
				
	 Senior Non-Exempt
	  	6	  	10	%	 	12.5	%
	 Non-Exempt
	  	5	  	10	%	 	12.5	%
	 Non-Exempt
	  	2-4	  	8	%	 	10	%
	 Non-Exempt
	  	1	  	6	%	 	7.5	%

  
 For employees with less than one year
of service, the bonus will be pro-rated based on the actual base pay earnings during the bonus year. Overtime earnings are not eligible to be included in bonus calculations. 
  
 Awards pursuant to the plan are based upon two factors: Company and Individual. The Company factor represents the degree to which we
achieved our overall corporate goals in a given year. Each employee also is given an Individual factor by his or her supervisor to reflect the employee’s performance against his or her individual goals for the year. Each factor can be assigned
a value of up to 125% for maximum performance. Thus, depending on the performance of the Company and the individual employee, an employee may receive up to 125% of his or her target bonus. 

 Each of the Company and Individual factors is itself separately weighted for each employee. The weighting assigned to
each factor varies by employee depending on the role he or she plays with the Company and his or her applicable pay band. For example, for the members of the company’s management team, the Company factor is weighted significantly higher than
the Individual factor in order to ensure that the bonus system for the company’s management team is closely tied to the company’s performance. 
  
 The weighting of the factors is as follows: 
  

							
	 Exempt Positions

	  	Company Factor

	 	 	Individual Factor

	 
	 Pay Bands 16A, 16B, 17
	  	70	%	 	30	%
	 Pay Bands 15A, 15B
	  	60	%	 	40	%
	 All others
	  	50	%	 	50	%

  
 For any bonus funds to be made
available, we must achieve 75% or more of our Company goals for the year, and the individual employee must also achieve at least 75% of his or her individual goals for the year, in each case after giving effect to the weighting described above. This
threshold does not apply with respect to the guaranteed portion of the bonus described below. 
  
 To determine the actual bonus paid, an employee’s target payout percentage is multiplied by the sum of the Company factor plus the Individual factor as each is weighted for such employee. The result of that
calculation is then multiplied by the employee’s target bonus. Notwithstanding the foregoing, in order to promote employee retention during the critical period following the Company’s January 2004 restructuring, for each employee that was
employed at the time of our January 2004 restructuring or is hired through October 2004, 50% of the target bonus for each of 2004 and 2005 is guaranteed, up to a maximum guarantee of $50,000. The guaranteed portion of the bonus does not apply to the
Company’s Chief Executive Officer, and is available to every other eligible employee only if he or she is employed at the time that the applicable bonus is paid. 
  
 Bonuses, if any, are paid during the first quarter of the year immediately following the year being measured.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00076-of-00352.parquet"}]]